Gapping down
In reaction to disappointing earnings/guidance/SSS: NAV -4%, VRNT -3.3%, CYBX -1.7%, SJM -1.1%, DRWI -0.8%
Select Large Pharma names showing weakness: SHPG -1.4%, GSK -1.2%, AZN -1.1%, NVS -0.9%
Select metals/mining stocks trading lower: AU -3.3%, GFI -2.4%, HMY -2.1%, BHP -1.8%, SLV -1.4%, GDX -1.2%
Other news: SGMO -6.4% (Sangamo BioSci disclosed Philip Gregory, senior vice president, research and chief scientific officer, resigned ), NBG -5.5% (concern over lack of progress in Greece), OXLC -4.7% (announces an underwritten public offering of 2.25 mln shares of its common stock ), VLTC -3.7% (modestly pulling back following yday's 48% gain), RADA -2.8% (filed for $14.95 mln offering of ordinary shares), VWR -2.6% (prices public offering of 16,000,000 shares of common stock by selling stockholder Varietal Distribution Holdings at $26.25 per share), ZQK -2.4% (disclosed resignation of Elizabeth Dolan from the Board based on her belief that she was prevented from fulfilling her duties as a director), AAOI -2.4% (files for $140 mln mixed securities shelf offering), GRBK -2.3% ( files for $200 mln offering of common stock ), BLUE -2% (Celgene and bluebird bio to develop Anti-BCMA Product Candidates; bluebird bio regains rights to CAR T programs outside of BCMA), AER -1.2% (American Intl prices sale of ordinary shares of AerCap (AER); offers 71,184,686 ordinary shares and a private sale of 15,698,588 ordinary shares to AerCap), MOH -1% (prices its offering of 5 mln share of common stock at $67.75/share)
Analyst comments: VZ -2.2% (downgraded to Neutral from Overweight at JP Morgan), JWN -1.3% (downgraded to Neutral from Outperform at Credit Suisse), DDS -1% (downgraded to Underperform from Neutral at Credit Suisse), XLNX -1% (downgraded to Market Perform at FBR Capital), WEN -1% (downgraded to Neutral from Outperform at Wedbush), OCR -0.5% (downgraded to Neutral from Buy at Goldman)
In reaction to disappointing earnings/guidance/SSS: NAV -4%, VRNT -3.3%, CYBX -1.7%, SJM -1.1%, DRWI -0.8%
Select Large Pharma names showing weakness: SHPG -1.4%, GSK -1.2%, AZN -1.1%, NVS -0.9%
Select metals/mining stocks trading lower: AU -3.3%, GFI -2.4%, HMY -2.1%, BHP -1.8%, SLV -1.4%, GDX -1.2%
Other news: SGMO -6.4% (Sangamo BioSci disclosed Philip Gregory, senior vice president, research and chief scientific officer, resigned ), NBG -5.5% (concern over lack of progress in Greece), OXLC -4.7% (announces an underwritten public offering of 2.25 mln shares of its common stock ), VLTC -3.7% (modestly pulling back following yday's 48% gain), RADA -2.8% (filed for $14.95 mln offering of ordinary shares), VWR -2.6% (prices public offering of 16,000,000 shares of common stock by selling stockholder Varietal Distribution Holdings at $26.25 per share), ZQK -2.4% (disclosed resignation of Elizabeth Dolan from the Board based on her belief that she was prevented from fulfilling her duties as a director), AAOI -2.4% (files for $140 mln mixed securities shelf offering), GRBK -2.3% ( files for $200 mln offering of common stock ), BLUE -2% (Celgene and bluebird bio to develop Anti-BCMA Product Candidates; bluebird bio regains rights to CAR T programs outside of BCMA), AER -1.2% (American Intl prices sale of ordinary shares of AerCap (AER); offers 71,184,686 ordinary shares and a private sale of 15,698,588 ordinary shares to AerCap), MOH -1% (prices its offering of 5 mln share of common stock at $67.75/share)
Analyst comments: VZ -2.2% (downgraded to Neutral from Overweight at JP Morgan), JWN -1.3% (downgraded to Neutral from Outperform at Credit Suisse), DDS -1% (downgraded to Underperform from Neutral at Credit Suisse), XLNX -1% (downgraded to Market Perform at FBR Capital), WEN -1% (downgraded to Neutral from Outperform at Wedbush), OCR -0.5% (downgraded to Neutral from Buy at Goldman)